Pioneering the discovery of membrane-permeable & orally available cyclic-peptides

Pioneering the discovery of membrane-permeable & orally available cyclic-peptides

Pioneering the discovery of membrane-permeable & orally available cyclic-peptides

We're taking a mission-driven approach

Insamo’s mission is to transform how we discover drugs for some of the most challenging diseases.

Our platform's pioneering capability lies in its automated process of designing, synthesizing, and testing at an unprecedented scale. Our groundbreaking approach enables us to iterate our design cycle using trillions of proprietary experimental data points across an astronomical drug-like chemical space which we believe sets an entirely new standard for the application of scalable machine learning to drug design.

Co-Founder & CEO

We're taking a mission-driven approach

Insamo’s mission is to transform how we discover drugs for some of the most challenging diseases.

Our platform's pioneering capability lies in its automated process of designing, synthesizing, and testing at an unprecedented scale. Our groundbreaking approach enables us to iterate our design cycle using trillions of proprietary experimental data points across an astronomical drug-like chemical space which we believe sets an entirely new standard for the application of scalable machine learning to drug design.

Co-Founder & CEO

We're taking a mission-driven approach

Insamo’s mission is to transform how we discover drugs for some of the most challenging diseases.

Our platform's pioneering capability lies in its automated process of designing, synthesizing, and testing at an unprecedented scale. Our groundbreaking approach enables us to iterate our design cycle using trillions of proprietary experimental data points across an astronomical drug-like chemical space which we believe sets an entirely new standard for the application of scalable machine learning to drug design.

Co-Founder & CEO

Our team

Tim Craven

CEO

Toby Passioura

CSO

Glen McIntyre

COO

Our team

Tim Craven

CEO

Toby Passioura

CSO

Glen McIntyre

COO

Our team

Tim Craven

CEO

Toby Passioura

CSO

Glen McIntyre

COO

Our investors

Our investors

Our investors

INSAMO
© 2024 Insamo, Inc. All rights reserved.
UNITED STATES
Insamo, Inc.
2630 Bancroft Way Berkeley, CA 94704
AUSTRALIA
Insamo South Pty. Ltd.
12-16 Chippen St.
Chippendale, NSW 2008
INSAMO
© 2024 Insamo, Inc. All rights reserved.
UNITED STATES
Insamo, Inc.
2630 Bancroft Way Berkeley, CA 94704
AUSTRALIA
Insamo South Pty. Ltd.
12-16 Chippen St.
Chippendale, NSW 2008
INSAMO
© 2024 Insamo, Inc. All rights reserved.
UNITED STATES
Insamo, Inc.
2630 Bancroft Way Berkeley, CA 94704
AUSTRALIA
Insamo South Pty. Ltd.
12-16 Chippen St.
Chippendale, NSW 2008